Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | June 29, 2022 02:42pm

Gainers

  • Allena Pharma (NASDAQ:ALNA) stock moved upwards by 166.4% to $0.32 during Wednesday's regular session. Trading volume for Allena Pharma's stock is 456.9 million as of 13:30 EST. This is 4213.0% of its average full-day volume over the last 100 days. The company's market cap stands at $28.4 million.
  • Brickell Biotech (NASDAQ:BBI) shares rose 47.55% to $0.17. Trading volume for this security as of 13:30 EST is 144.5 million, which is 2601.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $20.5 million.
  • Decibel Therapeutics (NASDAQ:DBTX) shares rose 43.77% to $3.81. Trading volume for Decibel Therapeutics's stock is 3.1 million as of 13:30 EST. This is 4022.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $95.1 million.
  • HTG Molecular Diagnostics (NASDAQ:HTGM) stock rose 41.67% to $1.19. As of 13:30 EST, this security is trading at a volume of 81.1 million shares, making up 6016.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.2 million.
  • Avenue Therapeutics (NASDAQ:ATXI) shares increased by 26.48% to $0.31. As of 13:30 EST, this security is trading at a volume of 3.1 million shares, making up 980.5% of its average full-day volume over the last 100 days. The company's market cap stands at $6.8 million.
  • AcelRx Pharmaceuticals (NASDAQ:ACRX) shares increased by 24.95% to $0.27. Trading volume for this security as of 13:30 EST is 5.8 million, which is 429.8% of its average full-day volume over the last 100 days. The company's market cap stands at $40.2 million.

Losers

  • Aileron Therapeutics (NASDAQ:ALRN) shares decreased by 31.9% to $0.28 during Wednesday's regular session. As of 13:30 EST, Aileron Therapeutics's stock is trading at a volume of 3.0 million, which is 1003.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $25.4 million.
  • Exicure (NASDAQ:XCUR) stock fell 29.69% to $0.09. Exicure's stock is trading at a volume of 36.2 million shares as of 13:30 EST. This is 290.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $11.0 million.
  • Agile Therapeutics (NASDAQ:AGRX) stock fell 27.06% to $1.76. The current volume of 25.2 million shares is 188.8% of Agile Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $7.9 million.
  • Icosavax (NASDAQ:ICVX) stock fell 27.02% to $6.14. Trading volume for this security as of 13:30 EST is 455.3K, which is 121.1% of its average full-day volume over the last 100 days. The company's market cap stands at $244.1 million.
  • Endo International (NASDAQ:ENDP) stock declined by 18.68% to $0.58. Endo International's stock is trading at a volume of 136.8 million shares as of 13:30 EST. This is 608.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $135.7 million.
  • Viveve Medical (NASDAQ:VIVE) shares decreased by 16.21% to $0.69. Trading volume for this security as of 13:30 EST is 490.4K, which is 293.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACRX AGRX ALNA ALRN ATXI BBI DBTX ENDP HTGM ICVX VIVE XCUR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist